Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ARTLW

Artelo Biosciences (ARTLW)

Artelo Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARTLW
FechaHoraFuenteTítuloSímboloCompañía
13/05/202408:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLWArtelo Biosciences Inc
04/03/202415:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLWArtelo Biosciences Inc
01/03/202417:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLWArtelo Biosciences Inc
19/05/202016:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARTLWArtelo Biosciences Inc
18/05/202016:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARTLWArtelo Biosciences Inc
08/05/202015:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARTLWArtelo Biosciences Inc
15/04/202005:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARTLWArtelo Biosciences Inc
15/04/202005:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARTLWArtelo Biosciences Inc
13/04/202015:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARTLWArtelo Biosciences Inc
13/04/202005:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARTLWArtelo Biosciences Inc
07/04/202005:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARTLWArtelo Biosciences Inc
14/02/202015:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARTLWArtelo Biosciences Inc
18/11/201907:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewe...NASDAQ:ARTLWArtelo Biosciences Inc
14/11/201908:00GlobeNewswire Inc.Artelo Biosciences to Present at the Annual Investival Showcase in LondonNASDAQ:ARTLWArtelo Biosciences Inc
29/10/201907:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART2...NASDAQ:ARTLWArtelo Biosciences Inc
22/10/201908:00GlobeNewswire Inc.Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:ARTLWArtelo Biosciences Inc
18/09/201907:00GlobeNewswire Inc.Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature MedicineNASDAQ:ARTLWArtelo Biosciences Inc
15/07/201915:01GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ARTLWArtelo Biosciences Inc
25/06/201912:00GlobeNewswire Inc.Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Optio...NASDAQ:ARTLWArtelo Biosciences Inc
21/06/201912:50GlobeNewswire Inc.Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to NasdaqNASDAQ:ARTLWArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTLW